These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 21787230)
21. Comparative study using Raman microspectroscopy reveals spectral signatures of human induced pluripotent cells more closely resemble those from human embryonic stem cells than those from differentiated cells. Tan Y; Konorov SO; Schulze HG; Piret JM; Blades MW; Turner RF Analyst; 2012 Oct; 137(19):4509-15. PubMed ID: 22888493 [TBL] [Abstract][Full Text] [Related]
22. Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells. Sumer H; Jones KL; Liu J; Heffernan C; Tat PA; Upton KR; Verma PJ Stem Cells Dev; 2010 Feb; 19(2):239-46. PubMed ID: 19637940 [TBL] [Abstract][Full Text] [Related]
24. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells. Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079 [TBL] [Abstract][Full Text] [Related]
25. Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells. Pei H; Li H; Xu L; Zhang B; Zhang H; Jia Y; Liang L; Xie X; Fan Z; Yang Z; Wang X; Song F; He L; Yue W; Pei X Arterioscler Thromb Vasc Biol; 2023 May; 43(5):697-712. PubMed ID: 36951064 [TBL] [Abstract][Full Text] [Related]
26. Pluripotent stem cells derived from mouse primordial germ cells by small molecule compounds. Kimura T; Kaga Y; Sekita Y; Fujikawa K; Nakatani T; Odamoto M; Funaki S; Ikawa M; Abe K; Nakano T Stem Cells; 2015 Jan; 33(1):45-55. PubMed ID: 25186651 [TBL] [Abstract][Full Text] [Related]
27. Enhanced generation of human induced pluripotent stem cells by ectopic expression of Connexin 45. Ke Q; Li L; Yao X; Lai X; Cai B; Chen H; Chen R; Zhai Z; Huang L; Li K; Hu A; Mao FF; Xiang AP; Tao L; Li W Sci Rep; 2017 Mar; 7(1):458. PubMed ID: 28352086 [TBL] [Abstract][Full Text] [Related]
28. Conversion of genomic imprinting by reprogramming and redifferentiation. Kim MJ; Choi HW; Jang HJ; Chung HM; Arauzo-Bravo MJ; Schöler HR; Do JT J Cell Sci; 2013 Jun; 126(Pt 11):2516-24. PubMed ID: 23525019 [TBL] [Abstract][Full Text] [Related]
29. Proteomic identification of RREB1, PDE6B, and CD209 up-regulated in primitive gut tube differentiated from human embryonic stem cells. Lee DH; Ko JJ; Ji YG; Chung HM; Hwang T Pancreas; 2012 Jan; 41(1):65-73. PubMed ID: 21792086 [TBL] [Abstract][Full Text] [Related]
30. Comparative Metabolomic Profiling of Rat Embryonic and Induced Pluripotent Stem Cells. Sherstyuk VV; Yanshole LV; Zelentsova EA; Melnikov AD; Medvedev SP; Tsentalovich YP; Zakian SM Stem Cell Rev Rep; 2020 Dec; 16(6):1256-1265. PubMed ID: 33047280 [TBL] [Abstract][Full Text] [Related]
31. Induced pluripotent stem cells: progress and future perspectives in the stem cell world. Rezanejad H; Matin MM Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654 [TBL] [Abstract][Full Text] [Related]
32. In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells. Takayama N; Eto K Methods Mol Biol; 2012; 788():205-17. PubMed ID: 22130710 [TBL] [Abstract][Full Text] [Related]
33. Generation and characterization of reprogrammed sheep induced pluripotent stem cells. Liu J; Balehosur D; Murray B; Kelly JM; Sumer H; Verma PJ Theriogenology; 2012 Jan; 77(2):338-46.e1. PubMed ID: 21958637 [TBL] [Abstract][Full Text] [Related]
34. Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells. Luzzani C; Solari C; Losino N; Ariel W; Romorini L; Bluguermann C; Sevlever G; Barañao L; Miriuka S; Guberman A Biochem Biophys Res Commun; 2011 Jul; 410(4):816-22. PubMed ID: 21703227 [TBL] [Abstract][Full Text] [Related]
35. A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs. Choi J; Lee S; Mallard W; Clement K; Tagliazucchi GM; Lim H; Choi IY; Ferrari F; Tsankov AM; Pop R; Lee G; Rinn JL; Meissner A; Park PJ; Hochedlinger K Nat Biotechnol; 2015 Nov; 33(11):1173-81. PubMed ID: 26501951 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive proteogenomic analysis of human embryonic and induced pluripotent stem cells. Parrotta EI; Scalise S; Taverna D; De Angelis MT; Sarro G; Gaspari M; Santamaria G; Cuda G J Cell Mol Med; 2019 Aug; 23(8):5440-5453. PubMed ID: 31237115 [TBL] [Abstract][Full Text] [Related]
37. Role of mass spectrometry-based proteomics in the study of cellular reprogramming and induced pluripotent stem cells. Benevento M; Munoz J Expert Rev Proteomics; 2012 Aug; 9(4):379-99. PubMed ID: 22967076 [TBL] [Abstract][Full Text] [Related]
38. Generation of induced pluripotent stem cells (iPSCs) from human foreskin fibroblasts. Erdlenbruch F; Rohwedel J; Ralfs P; Thomitzek A; Kramer J; Cakiroglu F Stem Cell Res; 2018 Dec; 33():79-82. PubMed ID: 30321832 [TBL] [Abstract][Full Text] [Related]